Prescription drug · ANDA
Flucytosine NDC 42794-009
Flucytosine 250 mg/1 · Capsule · Oral · Sigmapharm Laboratories, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 42794-009-08 | 4279400090842794000908 | 30 CAPSULE in 1 BOTTLE (42794-009-08)Marketed from Jun 1, 2018 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Flucytosine
- Generic name (nonproprietary)
- flucytosine
- Active ingredients
- Flucytosine — 250 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Sigmapharm Laboratories, LLCNDC labeler code 42794
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 201566
- Marketing start
- Listing expires
- Other FDA classes
- Nucleoside Analog (EXT)
- Identifiers
- Product ID 42794-009_f1f1b263-dcab-60e7-e053-2995a90ae493SPL ID f1f1b263-dcab-60e7-e053-2995a90ae493SPL set ID 3f2f67a8-2d13-4a7c-8e90-8b625c6ed98eRxCUI 197702, 197703UNII D83282DT06UPC 0342794010088, 0342794009082
- Pharmacologic class
- Nucleoside Analog Antifungal
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N442794000908followed by a unit qualifier and the quantityPackage 42794-0009-08. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Flucytosine Capsules, USP are indicated only in the treatment of serious infections caused by susceptible strains of Candida and/or Cryptococcus . Candida: Septicemia, endocarditis and urinary system infections have been effectively treated with flucytosine. Limited trials in pulmonary infections justify the use of flucytosine. Cryptococcus: Meningitis and pulmonary infections have been treated effectively. Studies in septicemias and urinary tract infections are limited, but good responses have been reported. Flucytosine Capsules, USP should be used in combination with amphotericin B for the treatment of systemic candidiasis and cryptococcosis because of the emergence o…
Excerpt only. Read the full label for complete information.
About NDC 42794-009
- What is NDC 42794-009?
- 42794-009 is the product NDC for Flucytosine, Flucytosine 250 mg/1 capsule, listed with the FDA by Sigmapharm Laboratories, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Flucytosine.
- What is the active ingredient?
- Flucytosine.
- Who is the labeler?
- Sigmapharm Laboratories, LLC, NDC labeler code 42794. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Flucytosine?
- 16 other product NDCs are listed under this name. See all Flucytosine NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Flucytosine products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Flucytosine | Flucytosine 250 mg/1 | CapsuleOral | Laurus Labs Limited | 42385-983 | 42385-0983-0142385-0983-27 |
| Flucytosine | Flucytosine 500 mg/1 | CapsuleOral | Laurus Labs Limited | 42385-984 | 42385-0984-0142385-0984-27 |
| Flucytosine | Flucytosine 250 mg/1 | CapsuleOral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-860 | 23155-0860-0123155-0860-03 |
| Flucytosine | Flucytosine 500 mg/1 | CapsuleOral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-861 | 23155-0861-0123155-0861-03 |
| Flucytosine | Flucytosine 250 mg/1 | CapsuleOral | American Health Packaging | 60687-599 | 60687-0599-21 |
| Flucytosine | Flucytosine 500 mg/1 | CapsuleOral | American Health Packaging | 60687-610 | 60687-0610-21 |
| Flucytosine | Flucytosine 250 mg/1 | CapsuleOral | AvPAK | 50268-331 | 50268-0331-12 |
| Flucytosine | Flucytosine 500 mg/1 | CapsuleOral | AvPAK | 50268-332 | 50268-0332-12 |
| Flucytosine | Flucytosine 250 mg/1 | CapsuleOral | Aurobindo Pharma Limited | 59651-331 | 59651-0331-01 |
| Flucytosine | Flucytosine 500 mg/1 | CapsuleOral | Sigmapharm Laboratories, LLC | 42794-010 | 42794-0010-08 |
Other NDCs under ANDA 201566
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Flucytosine | Flucytosine 500 mg/1 | CapsuleOral | Sigmapharm Laboratories, LLC | 42794-010 |